Biotage AB (publ) announced that while the business of the company continues to perform well, following consultation with the Board Tomas Blomquist will leave his role as CEO & President of the company with immediate effect. The Chairman of the Board, Torben Jørgensen, has been appointed by the Board of Directors as interim CEO while the process of recruiting a new CEO is finalized. As Torben Jørgensen takes on the role as interim CEO, he has resigned as Chairman of the Board but he will remain as a Board member. Kieran Murphy has been appointed as Chairman of the Board during Torben Jørgensen's period as interim CEO, which has been decided in dialogue with the Nomination Committee. Kieran Murphy also takes Torben Jørgensen's role as acting member
of the Nomination Committee.